Inducing Pluripotency Every Time

By removing a single gene, adult cells can be reprogrammed into a stem-like state with nearly 100 percent efficiency.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, A. TANAKA ET AL.In 2007, Japanese scientist Shinya Yamanaka reprogrammed adult skin cells into a stem-like state using a quartet of genes. These induced pluripotent stem cells (iPSCs) earned Yamanaka a Nobel Prize in 2012, kicked off a flood of research, and promised a way of growing bespoke tissues.

But reprogramming techniques are still notoriously inefficient. At best, they can convert around 10 percent of adult cells into iPSCs; often, they only manage around 0.1 percent. Worse still, the process seemed random, and it was impossible to predict which cells would be successfully reprogrammed.

This roadblock may be a thing of the past. Jacob Hanna at Israel’s Weizmann Institute of Science has found a straightforward way of producing iPSCs with almost 100 percent efficiency. Hanna’s team simply disabled a single gene, Mbd3, which seems to repress pluripotency.

“I never believed we’d get to 100 percent,” said Hanna. “This shows that the process of reprogramming need not be random and inefficient. You can really control the cells much better than we thought.” He also noted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies